Regulus Therapeutics Inc. (NASDAQ:RGLS) Short Interest Update

Regulus Therapeutics Inc. (NASDAQ:RGLS – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 116,300 shares, a drop of 7.3% from the January 15th total of 125,500 shares. Approximately 0.7% of the shares of the company are […]

Leave a Reply

Your email address will not be published.

Previous post Kolhatkar: Airbnb driving up housing $$ for everyone
Next post Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Update